Biography

Stuart Rich, M.D., is Director of the Bluhm Cardiovascular Institute Pulmonary Vascular Disease Program, and Professor of Medicine at the Northwestern University Feinberg School of Medicine. Dr. Rich did is residency training in medicine at Washington University in St. Louis, and fellowship in cardiology at the University of Chicago. Dr. Rich is one of the world’s most recognized experts on pulmonary vascular diseases. For more than three decades he has dedicated his research and clinical efforts to finding better solutions for pulmonary hypertension. His career began at the University of Illinois where he was principle investigator for the NIH Registry on Primary Pulmonary Hypertension, the first of its kind, and has been the leader of the largest clinical center in the U.S. for evaluating and treating patients with pulmonary hypertension since 1980. Dr. Rich has conducted pioneering research on the molecular mechanisms, epidemiology, clinical presentation, natural history and treatments of the disease. He has been a leader in the development of virtually every new treatment for pulmonary hypertension, as well as the use of therapeutic procedures and devices. His pioneering research has led to a greater understanding of all types of pulmonary hypertension. Dr. Rich has been listed among the country’s top 1% of doctors by Castle Connolly Ltd. and Chicago magazine for more than 20 consecutive years. He has published hundreds of clinical articles and book chapters on pulmonary hypertension. In addition, he is Co-Founder of the Pulmonary Vascular Research Institute, a global health professional organization that is committed to bringing advances in treating pulmonary vascular diseases to the developing world. In 2014 he received the Heart for Hope Legacy Award from the Pulmonary Hypertension Association, and in 2015 he received the Lifetime Achievement Award from the Pulmonary Vascular Research Institute.

Read More